Northpond Ventures
Latest statistics and disclosures from Northpond Ventures's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VIGL, TBIO, CADL, and represent 100.00% of Northpond Ventures's stock portfolio.
- Northpond Ventures has $21M in assets under management (AUM), dropping by -39.49%.
- Central Index Key (CIK): 0001911245
Tip: Access up to 7 years of quarterly data
Positions held by Northpond Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Northpond Ventures
Northpond Ventures holds 3 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vigil Neuroscience (VIGL) | 67.8 | $14M | 4.2M | 3.38 |
|
|
| Codex Dna (TBIO) | 18.7 | $3.9M | 9.8M | 0.40 |
|
|
| Candel Therapeutics (CADL) | 13.5 | $2.8M | 1.9M | 1.47 |
|
Past Filings by Northpond Ventures
SEC 13F filings are viewable for Northpond Ventures going back to 2021
- Northpond Ventures 2023 Q4 filed Feb. 14, 2024
- Northpond Ventures 2023 Q3 filed Nov. 14, 2023
- Northpond Ventures 2023 Q2 filed Aug. 14, 2023
- Northpond Ventures 2023 Q1 filed May 15, 2023
- Northpond Ventures 2022 Q4 filed Feb. 1, 2023
- Northpond Ventures 2022 Q3 filed Nov. 14, 2022
- Northpond Ventures 2022 Q2 filed Aug. 1, 2022
- Northpond Ventures 2022 Q1 filed May 16, 2022
- Northpond Ventures 2021 Q4 filed Feb. 15, 2022